PFAS in EU Cosmetics: What the Universal REACH Restriction Means for Your Formulations

In 2021, researchers at the University of Notre Dame tested 231 cosmetic products purchased from major US and Canadian retailers. In foundations and eye products alone, 56% showed high total fluorine content — the primary analytical marker for PFAS. Mascaras came in at 63%. The researchers hadn’t gone looking for a crisis. They were simply measuring what was there.

European regulators noticed.

PFAS — per- and polyfluoroalkyl substances — have been accumulating in cosmetic formulations for decades, largely because they work exceptionally well. They create the silky slip in luxury foundations. They keep mascara in place through a twelve-hour day. They make waterproof sunscreens actually waterproof. But PFAS don’t break down. Not in the environment, not in human tissue, and increasingly, not in regulatory patience. The EU’s response is now moving through the legislative machinery — and the timeline is closer than most brands have planned for.

What’s Actually in Your INCI List

The term “PFAS” covers an enormous chemical family — thousands of individual substances — unified by the presence of at least one fully fluorinated carbon-fluorine bond. In cosmetics, the most common applications cluster around a few functional roles:

Film formers: Polytetrafluoroethylene (PTFE — the same chemistry as Teflon) is used in foundations, primers, and lipsticks to create a smooth, transfer-resistant film. It’s one of the easier PFAS to identify on an INCI list because it appears by name.

Surfactants and emulsifiers: Compounds such as perfluoropolymethylisopropyl ether help stabilise emulsions, particularly in high-performance skincare where water and oil phases need to remain homogeneous across wide temperature ranges.

Emollients: Fluorinated silicones deliver the cushioned skin feel that prestige moisturisers charge a premium for. They’re less well-known in regulatory circles than PTFE but present in a meaningful share of premium EU formulations.

Water-repellent agents: Particularly relevant in sport cosmetics, waterproof mascaras, and high-SPF sunscreens designed to resist perspiration and immersion.

Some of these appear clearly on INCI lists. Others don’t. Undisclosed processing aids, proprietary trade names assigned by ingredient manufacturers, and multi-tier supply chains all create gaps between what’s on the label and what’s analytically present in the finished product. That opacity is precisely what makes REACH compliance for PFAS so difficult to manage with a spreadsheet and good intentions.

The Universal REACH Restriction: Where It Stands

In January 2023, the national authorities of Denmark, Germany, the Netherlands, Norway, and Sweden submitted a joint restriction dossier to ECHA — the most comprehensive ever proposed under REACH Regulation (EC) No 1907/2006. The proposal targets all PFAS as a chemical group. Not individual substances, one at a time. All of them.

That approach is deliberate. Environmental chemists and regulators had watched manufacturers substitute one PFAS for another each time a specific substance was restricted — swapping long-chain perfluorocarboxylic acids for short-chain alternatives like PFBS or HFPO-DA, which initially carried less regulatory scrutiny. A group restriction closes that substitution loop permanently.

The proposal covers manufacturing, use, and placing on the market of PFAS-containing mixtures and articles. Cosmetics, as mixtures placed on the EU market, fall squarely within scope. ECHA’s Risk Assessment Committee (RAC) and Socioeconomic Analysis Committee (SEAC) conducted multi-year technical review of the dossier, evaluating both the hazard evidence and the socioeconomic impacts of broad restriction. The file then moved into the European Commission’s legislative process — slow by design, but binding at the end.

Transitional periods in the draft restriction vary by use category. For many consumer product applications, the envisaged transition is 18 months from the date the restriction enters into force. Specialised industrial uses carry derogations extending to 12 years. Consumer cosmetics are firmly in the short-transition category. Brands that haven’t audited their formulations are already running out of comfortable runway.

What Already Applies Right Now

While the universal restriction moves through the legislative process, PFAS are not unregulated in EU cosmetics today. Several are already listed in Annex II of Regulation (EC) No 1223/2009 as prohibited substances. PFOS (perfluorooctane sulfonic acid) and its salts, PFOA (perfluorooctanoic acid), and a growing list of long-chain perfluorocarboxylic acids (C9 through C14 homologues) are all currently prohibited in finished cosmetic products placed on the EU market.

REACH Annex XVII adds further restriction for certain applications. And the SVHC Candidate List — which triggers Article 33 communication obligations — has been progressively populated with individual PFAS substances as ECHA assessments conclude.

The DGCCRF has been sampling cosmetics for restricted PFAS as part of France’s routine market surveillance programme. Positive findings trigger a well-established cascade: product withdrawal notification, entry into the SAFETY GATE rapid alert system, potential administrative fines, and reputational damage that outlasts the regulatory penalty by years. In 2023 and 2024, multiple cosmetics lines were flagged across European markets for containing restricted perfluorinated compounds that manufacturers apparently hadn’t screened for. None of those brands intended to be non-compliant. They simply hadn’t tested.

How to Actually Know What’s in Your Products

There are two distinct analytical approaches to PFAS screening in cosmetics, and understanding the difference between them is important for building a credible compliance programme.

Targeted analysis uses liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify and quantify specific PFAS compounds from a pre-defined target list. Validated methods like EPA Method 533 and adapted cosmetic matrix protocols can quantify individual substances at parts-per-trillion sensitivity — but only for compounds on the panel. Novel PFAS, or undisclosed formulation additives arriving from non-EU ingredient suppliers, can escape targeted panels entirely if they’re not on the list.

Total organic fluorine (TOF) screening takes a different approach. Combustion ion chromatography (CIC) and particle-induced gamma-ray emission (PIGE) spectroscopy measure total fluorine content rather than chasing individual compounds. A high TOF result doesn’t tell you which PFAS are present — but it flags a formulation for follow-up investigation. It’s a triage tool, not a quantification method. And it catches what targeted panels miss.

Best practice right now is a two-step approach: TOF screening to identify suspect product categories, followed by targeted LC-MS/MS to identify and quantify specific regulated or candidate substances. More expensive than a single-method run, certainly. But far less expensive than a RAPEX notification and the attendant product recall.

The Supplier Communication Gap

Most quality managers underestimate this part. Ingredient suppliers are not consistently forthcoming about PFAS content — partly because their own supply chains have multiple tiers, and partly because REACH SVHC disclosure obligations don’t cascade through ingredient distributors as efficiently as the regulation intends.

Under Article 33 of REACH, any supplier of an article containing an SVHC above 0.1% w/w concentration must communicate that information to business recipients, and to consumers on request, within 45 days of the request. But cosmetic ingredients sold as mixtures operate under a different part of the REACH framework, and many PFAS in cosmetic use hadn’t been formally placed on the SVHC Candidate List until recently. The disclosure infrastructure hasn’t fully caught up with the regulatory intent.

The practical response is to write explicit PFAS declarations into supplier quality agreements — not as a polite request, but as a contractual requirement. Ask for signed attestations confirming that no PFAS are intentionally used as ingredients, processing aids, or intentional impurities above defined thresholds. Audit those declarations periodically against analytical data. When a supplier can’t or won’t provide attestations, treat that as a risk signal worth escalating.

We’ve worked with European cosmetics brands that had to undergo full reformulation of core SKUs because a raw material supplier operating through a multi-tier chain couldn’t verify PFAS-free status for a specific emulsifier. The reformulation cost was significant. The cost of a SAFETY GATE notification would have been higher — and far harder to walk back commercially.

A Practical Audit Sequence for EU Brands

There’s no regulatory requirement to follow any particular sequence here, but brands that approach this systematically tend to move faster and waste less money.

1. Audit current INCI lists against existing prohibitions. Check Annex II of Regulation 1223/2009 and REACH Annex XVII for substances currently restricted. This is a desk exercise that flags obvious risks before you commission any analytical work.

2. Request PFAS declarations from suppliers for your top 20 SKUs by revenue. Start there, then extend to the full portfolio. Revenue-ranked prioritisation is defensible in an audit conversation.

3. Commission TOF screening on high-risk product categories. Foundations, mascaras, waterproof sunscreens, long-wear lip products, and sport cosmetics are the obvious starting points. Use results to prioritise targeted LC-MS/MS on flagged formulations.

4. Brief your formulation team on which functional claims correlate with PFAS chemistry. Waterproofing, transfer-resistance, and 24-hour wear are the primary signals. Start identifying alternative fluorine-free technologies now — silicone-based film formers, waxes, and crosspolymers have advanced considerably in recent years.

5. Monitor the ECHA restriction file for the adopted Annex XVII entry. The transitional provisions in the final restriction text — particularly the specific date of entry into force and any category-specific derogations for cosmetics — will determine your actual deadline.

Reformulation takes time. Ingredient qualification takes time. Supplier documentation takes time. The universal PFAS restriction has been advancing through EU legislative channels for over three years. Brands that wait for a Commission decision before acting will find themselves compressed against a transition deadline with a full reformulation programme still to execute.

Our team supports European cosmetics manufacturers through exactly this kind of regulatory intersection — from INCI audits and SVHC screening coordination to supplier qualification frameworks and REACH compliance documentation. The analytical work happens through our partner-lab network, with ISO 17025-accredited facilities capable of both TOF screening and targeted LC-MS/MS in cosmetic matrices. The regulatory interpretation and supplier communication strategy is where we add most value, because that’s where the complexity actually lives.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team

Talk to our team about EU market entry Contact us

Related from our network

• ISO 17025-accredited PFAS and chemical contaminant testing for cosmetics and personal care products — Qalitex Laboratories delivers targeted LC-MS/MS and total fluorine screening for cosmetic matrices, with reporting structured for EU regulatory submissions.
• PFAS and contaminant testing for brands entering the Canadian market under Health Canada requirements — Androxa provides chemical safety screening and supplier qualification support for cosmetics and NHP products seeking Canadian market compliance.